Journal
JOURNAL OF CLINICAL VIROLOGY
Volume 48, Issue -, Pages S20-S28Publisher
ELSEVIER
DOI: 10.1016/S1386-6532(10)70005-6
Keywords
Zoster; VZV; Antivirals; Management
Categories
Ask authors/readers for more resources
Herpes zoster (HZ; shingles) - a reactivation of the latent varicella zoster virus (VZV) - can cause significant morbidity. Its major complication is pain, particularly post-herpetic neuralgia (PHN). We will review the current management strategies available for the treatment of both acute HZ and PHN, including antiviral drugs, analgesic agents, anticonvulsants, tricyclic antidepressants and topical therapies. New molecules in development that show improved activity against VZV are also covered, and new drug targets are outlined. The role of translational neuroscience in moving towards a goal of finding disease-modifying treatments will be examined. (c) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available